REQUEST A DEMO
Total
USD $0.00
Search more companies

Noronic Pharmaceutical Private Limited (India)

Main Activities: Artificial and Synthetic Fibers and Filaments Manufacturing
Full name: Noronic Pharmaceutical Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Noronic Pharmaceutical Private Limited is an unlisted company, incorporated on 04/07/2016. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24302GJ2016PTC092775 and registration number is 092775. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
At-Indrad, Ls-763/2 Near Zedchem Ind, Indrad
Mahesana; Gujarat; Postal Code: 382715

Contact Details: Purchase the Noronic Pharmaceutical Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Noronic Pharmaceutical Private Limited report to view the information.
Outstanding Shares:
Purchase the Noronic Pharmaceutical Private Limited report to view the information.
Registered Capital:
Purchase the Noronic Pharmaceutical Private Limited report to view the information.
Incorporation Date:
July 04, 2016
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Noronic Pharmaceutical Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
147.03%
Total operating revenue
129.96%
Operating profit (EBIT)
66.06%
EBITDA
28.35%
Net Profit (Loss) for the Period
84.91%
Total assets
34.54%
Total equity
28.74%
Operating Profit Margin (ROS)
-0.91%
Net Profit Margin
-0.43%
Return on Equity (ROE)
6.79%
Debt to Equity Ratio
-36.06%
Quick Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?